Global Cerebral Embolic Protection Devices for TAVI Market Growth 2023-2029

Global Cerebral Embolic Protection Devices for TAVI Market Growth 2023-2029

Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.

LPI (LP Information)' newest research report, the “Cerebral Embolic Protection Devices for TAVI Industry Forecast” looks at past sales and reviews total world Cerebral Embolic Protection Devices for TAVI sales in 2022, providing a comprehensive analysis by region and market sector of projected Cerebral Embolic Protection Devices for TAVI sales for 2023 through 2029. With Cerebral Embolic Protection Devices for TAVI sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cerebral Embolic Protection Devices for TAVI industry.

This Insight Report provides a comprehensive analysis of the global Cerebral Embolic Protection Devices for TAVI landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cerebral Embolic Protection Devices for TAVI portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cerebral Embolic Protection Devices for TAVI market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cerebral Embolic Protection Devices for TAVI and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cerebral Embolic Protection Devices for TAVI.

The global Cerebral Embolic Protection Devices for TAVI market size is projected to grow from US$ 51 million in 2022 to US$ 134 million in 2029; it is expected to grow at a CAGR of 134 from 2023 to 2029.

Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%. Geographically speaking, cerebral embolic protection devices for TAVI currently have a market only in Europe and North America, with North America accounting for about 55% of the share. In terms of artery coverage cover, non-total artery coverage segment holds an important share of over 90%. In terms of application, hospital segment accounts for about 80% of the global share.

This report presents a comprehensive overview, market shares, and growth opportunities of Cerebral Embolic Protection Devices for TAVI market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Total Artery Coverage
Non-total Artery Coverage

Segmentation by application
Hopsital
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Venus
Claret Medical
Edwards Lifesciences

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cerebral Embolic Protection Devices for TAVI market?

What factors are driving Cerebral Embolic Protection Devices for TAVI market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cerebral Embolic Protection Devices for TAVI market opportunities vary by end market size?

How does Cerebral Embolic Protection Devices for TAVI break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.